Fig 1.
BMI and percentage weight loss (%WL) after SG and RYGB.
Values are reported as mean ± SEM. *P <0.05 between group difference.
Table 1.
Baseline characteristics of participants.
Fig 2.
Fasting and postprandial gut hormone levels after SG and RYGB.
Values are reported as model estimated mean ± SEM. *P <0.05, **P <0.01, ***P <0.001 within group difference; oP <0.05, ooP <0.01, oooP <0.001 between group difference.
Table 2.
Baseline characteristics and changes over time in body weight, glucose and plasma hormone levels after SG and RYGB.
Fig 3.
Fasting and postprandial glucose and insulin.
Values are reported as model estimated mean ± SEM. *P <0.05, **P <0.01, ***P <0.001 within group difference.
Fig 4.
HOMA-IR and correlation with percentage Weight Loss (%WL) after SG and RYGB.
Fig 5.
Visual analog scale results of appetitive ratings.
Values are AUC 0–120 min. *P <0.05, **P <0.01, ***P <0.001 within group difference.